The purpose of the Microscopy, Imaging and Cytometry Resources (MICR) Core is to enhance the peer reviewed funded research activities of KCI members whose research requires confocal microscopy, flow cytometry, small animal imaging and related techniques. To this end, during the current funding period the Core has facilitated 92 peer-reviewed publications by the cancer center members. The MICR Core is grouped in the Basic Research Core Cluster which, in addition to the MICR Core, includes the Proteomics and the Animal Model and Therapeutics Evaluation Cores. Capabilities and services include: confocal microscopy, multiphoton microscopy, conventional light microscopy, FRET and FRAP, TIRF and Atomic Force Microscopy, in vivo small animal imaging (including SPECT, CT, PET, x-ray, and optical imaging), flow cytometry and ratiometric analyses (e.g., intracellular pH and ion measurement studies), as well as three- and four- dimensional image reconstruction and quantitative measurements. MR imaging is also available through a collaborative effort between MICR and the MR Center. Our advanced imaging systems consist of a Zeiss LSM 410 confocal microscope equipped with six laser lines, a PerkinElmer UltraView ERS spinning disk confocal microscope equipped with three laser lines, a Zeiss LSM-510 META NLO confocal microscope with eight laser lines and multiphoton imaging, a Leica TCS-SP5 MP equipped with nine laser lines and multiphoton capability, a newly acquired Olympus/Bruker TIRF/AFM custom microscope and the cutting-edge Zeiss LSM 780 confocal microscope with six conventional laser lines and the InTune laser, a tunable white light laser with over 200 laser lines. Our flow cytometry systems include Becton Dickinson (BD) LSR II and BD FACSCanto II flow cytometers, a BD FACS Vantage SE SORP cell sorter and the newly acquired Amnis ImageStreamX Mark II imaging flow cytometer. The facility also provides conventional fluorescent microscopy through a Zeiss Axiophot Triple-Camera Photomicroscope, a Zeiss live cell imaging microscope with the state-of-the-art Apotome module capable of four dimensional imaging (3D in time). The in vivo small animal imaging unit is a newly upgraded combination of technologies made available to the core through the addition of Bruker In Vivo Extreme and MS FX Pro small animal optical/x-ray imagers, Siemens Inveon SPECT/CT and Concord MicroPET R4 small animal scanners. As mentioned above, small animal MRI is also available through collaborative efforts between MICR and the MR Center located next door. The analytical systems of the MICR Core include eight Apple and PC workstations with various analytical software and photographic quality printers and the MIP, Molecular Imaging Portal. MIP is a UNIX based central server with 45 TB storage capacity and a 74 TB robotic tape backup system as well as a dedicated applications server hosting the advance image analysis software, Matlab? and Definiens?, with two licenses each allowing up to two users access to each software simultaneously.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-38
Application #
9836630
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
38
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562
Vaishampayan, Ulka N; Podgorski, Izabela; Heilbrun, Lance K et al. (2018) Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res :
Mills, Anne M; Peres, Lauren C; Meiss, Alice et al. (2018) Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol :
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008

Showing the most recent 10 out of 826 publications